Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Seunghee Won is active.

Publication


Featured researches published by Seunghee Won.


Journal of Nervous and Mental Disease | 2010

Lifetime Prevalence and Correlates of Suicidal Ideation, Plan, and Single and Multiple Attempts in a Korean Nationwide Study

Hong Jin Jeon; Jun-Young Lee; Young Moon Lee; Jin Pyo Hong; Seunghee Won; Seong-Jin Cho; Jin-Yeong Kim; Sung Man Chang; Dong Soo Lee; Hae Woo Lee; Maeng Je Cho

This was the first Korean national study to evaluate prevalence and correlates of suicidal behavior, and to compare multiple and single attempts. A total of 6510 adults completed face-to-face interviews (response rate, 81.7%) through randomly chosen one-person-per-households. Lifetime prevalence and correlates were evaluated with the Korean version of Composite International Diagnostic Interview (K-CIDI), and a questionnaire to inquire about suicidal behaviors. The lifetime prevalence of suicidal ideation, plan, and attempt in South Korea was 15.2%, 3.3%, and 3.2% (single 2.1% and multiple 1.1%), respectively. Younger age was associated with attempts and more strongly associated with multiple attempts. Attempts were the most strongly associated with mood disorders, especially bipolar disorder, which was more strongly associated with multiple attempts. In conclusion, suicidal behaviors are highly prevalent in Korea, especially in young adults. Bipolar disorder was the most strongly associated disorder with suicide attempts, more with multiple attempts.


Journal of Affective Disorders | 2010

Unplanned versus planned suicide attempters, precipitants, methods, and an association with mental disorders in a Korea-based community sample

Hong Jin Jeon; Jun-Young Lee; Young Moon Lee; Jin Pyo Hong; Seunghee Won; Seong-Jin Cho; Jin-Yeong Kim; Sung Man Chang; Hae Woo Lee; Maeng Je Cho

BACKGROUND Studies have consistently reported that a considerable proportion of suicidal attempts are unplanned. We have performed the first direct comparison between planned and unplanned attempts including associated methods and precipitants. METHOD A total of 6510 adults, who had been randomly selected through a one-person-per-household method, completed interviews (response rate 81.7%). All were interviewed using the K-CIDI and a questionnaire for suicide. RESULTS Two hundred and eight subjects reported a suicide attempt in their lifetime, one-third of which had been unplanned. These individuals exhibited a lower level of education; however, no significant differences were found with regard to age, gender, marital and economic status. Further, 84.0% of unplanned attempters experienced previous suicidal ideation, experiencing their first attempt 1.9 years before ideation. Additionally, 94.4% of unplanned attempters had precipitants for attempts such as familial conflict and it was also found that methods such as the use of chemical agents or falling were three times more common in unplanned than planned attempters. With respect to unplanned attempters, they exhibited a significant association with alcohol use disorder, major depressive disorder, posttraumatic stress disorder, and bipolar disorder. In particular, bipolar disorder was found to be 3.5 times higher in these individuals. CONCLUSIONS Results have revealed that unplanned suicide attempters experience suicidal ideation and precipitants prior to their attempt. Further, attempts were associated with affective and alcohol use disorders. Therefore, in order to reduce the number of suicidal attempts, it may be useful to evaluate suicidal ideation concurrent to the treatment of existing mental disorders.


Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | 2015

Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder.

Do-Hoon Kim; Jiwoo Kim; Taehoon Koo; Hyerim Yun; Seunghee Won

Objective Schizophrenia and bipolar disorder are characterized by the presence of neurocognitive impairments on the psychosis continuum. The present study aimed to explore the shared and distinct endophenotypes between these disorders. Methods The study included 34 probands with remitted schizophrenia and 34 probands with euthymic bipolar disorder who had a history of psychotic symptoms that met the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) criteria, unaffected first-degree relatives of probands (31 relatives of probands with schizophrenia and 29 relatives of probands with bipolar disorder), and 34 healthy controls. Cognitive assessments were performed using the digit span, continuous performance, Rey auditory and visual learning, complex figure, verbal fluency, Wisconsin card sorting, and finger tapping tests. Results Probands with schizophrenia showed the most generalized and severe cognitive deficits across cognitive domains (working memory, verbal learning and memory, visual memory, verbal fluency, and executive function). Some domains of cognitive function (working memory, verbal learning, and memory) were also impaired in probands with bipolar disorder, but to a lesser degree than in probands with schizophrenia. All probands and relatives showed a common deficit in working memory compared to healthy controls. Relatives of probands with schizophrenia also showed verbal fluency dysfunction. Cognitive performance of all relatives was intermediate to the performance of both patients and healthy controls. Conclusion These findings suggest that a deficit in working memory could be a shared endophenotype of genetic vulnerability to schizophrenia and psychotic bipolar disorder, and verbal fluency could be a candidate endophenotype for schizophrenia specifically.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2009

Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial.

Young Sup Woo; Won-Myong Bahk; Duk-In Jon; Yeon Ho Joo; Won Kim; Jeong Seok Seo; Yong Min Ahn; Sang-Keun Chung; Seunghee Won; Young Chul Shin; Bo-Hyun Yoon; Sung-Hun Jung; Jeong Ho Seok; Yil-Seob Lee; Yooni Kim; Kyung Joon Min

The goal of this study was to assess the incidence of rash occurring in patients received lamotrigine to treat bipolar I disorder in a real world setting in Korea. We included a heterogeneous sample with multiple medications and medical comorbidities. Lamotrigine was added to the current therapy regime for DSM-IV bipolar I patients on an open-label basis for 12 weeks. The incidences of rash and other adverse events were assessed. The primary outcome measure was the incidence of rash. A total of 237 adult patients were included in the present study and 173 patients (73.0%) completed the 12 weeks of treatment. Thirty patients (12.7%) developed a rash, of whom 2 (0.8%) developed a serious rash. There were no patients who developed Stevens-Johnson syndrome or toxic epidermal necrolysis. The median time of rash onset was 16 days. As a group, patients who did not experience rash were significantly heavier than those who did. Our findings suggest that the incidence of serious rash associated with lamotrigine is low. The prescription of lamotrigine should be undertaken with appropriate consideration of the potential risk of adverse events including rash to the patient in relation to potential benefit from improvement of bipolar disorder.


Psychiatry and Clinical Neurosciences | 2014

One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics

Young Sup Woo; Won-Myong Bahk; Young-Eun Jung; Jong-Hyun Jeong; Hwang-Bin Lee; Seunghee Won; Kwang Heun Lee; Duk-In Jon; Bo-Hyun Yoon; Moon-Doo Kim; Kyung Joon Min

We compared the 1‐year rehospitalization rates of first‐episode bipolar manic patients who were discharged while being treated with lithium or valproate in combination with an atypical antipsychotic.


Psychiatry Investigation | 2017

Prevalence of Metabolic Syndrome in Patients with Schizophrenia in Korea: A Multicenter Nationwide Cross-Sectional Study.

Jung Sun Lee; Jun Soo Kwon; Daeho Kim; Sung Wan Kim; Jae-Jin Kim; Jong-Hoon Kim; Hee Jung Nam; Seunghyong Ryu; Il Ho Park; Suk Kyoon An; Hong Seok Oh; Seunghee Won; Kanguk Lee; Kyu Young Lee; Seung-Hwan Lee; Yu Sang Lee; Jung Seo Yi; Kyung Sue Hong; Yeon Ho Joo

Objective We designed a nationwide study with limited exclusion criteria to investigate the prevalence of metabolic syndrome (MetS) in Korea and its relationship with antipsychotic medications. Methods This multicenter, cross-sectional, and observational study included patients diagnosed with schizophrenia or schizoaffective disorder. Sixteen hospitals enrolled 845 patients aged 18 to 65 years prescribed any antipsychotic medication between August 2011 and August 2013. MetS was diagnosed using the criteria of the modified Adult Treatment Panel III of the National Cholesterol Education Program with the Korean abdominal obesity definition (waist circumference ≥85 cm in women, ≥90 cm in men). Results The prevalence of MetS in all patients was 36.5% and was significantly higher in men than women (men, 40.8%; women, 32.2%) and was significantly correlated with age [odds ratio (OR) 1.02] and duration of illness (OR 1.03). The prevalence of MetS across antipsychotic drugs in the major monotherapy group was as follows: 18.8% for quetiapine, 22.0% for aripiprazole, 33.3% for both amisulpride and paliperidone, 34.0% for olanzapine, 35% for risperidone, 39.4% for haloperidol, and 44.7% for clozapine. Conclusion The prevalence of MetS is very high in patients with schizophrenia or schizoaffective disorder. Screening and monitoring of MetS is also strongly recommended.


Psychiatry and Clinical Neurosciences | 2016

Current prescription pattern of maintenance treatments for bipolar patients in Korea: A focus on the transition from acute treatments.

Hoo Rim Song; Young-Joon Kwon; Won-Myong Bahk; Young Sup Woo; Hwang-Bin Lee; Jonghun Lee; Dae-Bo Lee; Sang-Yeol Lee; Moon-Doo Kim; Seunghee Won; Kwanghun Lee; Inki Sohn; Jung Goo Lee; Young-Chul Shin; Sang-Keun Chung; Sae-Heon Jang; Young Myo Jae; Bo-Hyun Yoon

We examined prescription patterns in maintenance treatment for recovered bipolar patients and compared these with acute treatments.


Psychiatry Investigation | 2015

Sociodemographic Factors and Comorbidities Associated with Remission from Alcohol Dependence: Results from a Nationwide General Population Survey in Korea

Song Yi Han; Maeng Je Cho; Seunghee Won; Jin Pyo Hong; Jae Nam Bae; Seong-Jin Cho; Jong-Ik Park; Jun-Young Lee; Hong Jin Jeon; Sung Man Chang

Objective The lifetime prevalence of alcohol dependence in South Korea remains higher than other countries. The aim of our study is to identify factors associated with remission from alcohol dependence. Methods Data from the Korean Epidemiological Catchment Area-Replication (KECA-R) study were used in our study. The Korean version of the Composite International Diagnostic Interview 2.1 (K-CIDI 2.1) was administered. Remission was defined as having no symptom of alcohol dependence for 12 months or longer at the time of the interview. Demographic and clinical variables putatively associated with remission from alcohol dependence were examined by t-test, chi-square-test and logistic regression analysis. Results The lifetime prevalence rate of alcohol dependence was 7.0%. Among them, 3.2% of the subjects were diagnosed with active alcohol dependence in the previous 12 months, and 3.8% were found to be in remission. Subjects in 35- to 44-year-old group, not living with partner group, and lower level of educational attainment group were more likely to be in the active alcohol dependence state. Of the comorbid mental disorders, dysthymia, anxiety disorder, nicotine use, and nicotine dependence were more common among the actively alcohol-dependent subjects. Conclusion There is considerable level of recovery from alcohol dependence. Attention to factors associated with remission from alcohol dependence may be important in designing more effective treatment and prevention programs in this high-risk population.


Asia-pacific Psychiatry | 2014

Is it useful to use the Korean version of the mood disorder questionnaire for assessing bipolar spectrum disorder among Korean college students

Seung Oh Bae; Moon Doo Kim; Jung Goo Lee; Jeong-Seok Seo; Seunghee Won; Young Sup Woo; Jeong-Ho Seok; Won Kim; Se Joo Kim; Kyung Joon Min; Duk-In Jon; Young Chul Shin; Won Myong Bahk; Bo-Hyun Yoon

The purpose of this study was to assess the usefulness of the Korean version of the Mood Disorder Questionnaire (K‐MDQ) as a screening tool for the identification of bipolar spectrum disorder (BSD) among Korean college students.


Clinical Psychopharmacology and Neuroscience | 2017

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

Young Sup Woo; In Hee Shim; Sang-Yeol Lee; Dae-Bo Lee; Moon-Doo Kim; Young-Eun Jung; Jonghun Lee; Seunghee Won; Duk-In Jon; Won-Myong Bahk

Objective Although aripiprazole has been widely used to treat various psychiatric disorders, little is known about the adequate dosage for Asian patients in clinical practice. Hence, we evaluated the initial and maximum doses of aripiprazole from 2004 to 2014 to estimate the appropriate dosage for Korean psychiatric inpatients in clinical practice. Methods In this retrospective study, we reviewed the medical records of patients who were hospitalized in five university hospitals in Korea from March 2004 to December 2014. The psychiatric diagnosis according to the text revision of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition during index hospitalization and the initial and maximum doses of aripiprazole were evaluated. Results There were 74 patients in Wave 1 (2004–2006), 201 patients in Wave 2 (2007–2010), and 353 patients in Wave 3 (2011–2014). The initial doses of aripiprazole in all diagnostic groups were significantly lower in Wave 3 than in Wave 2. The maximum doses of aripiprazole in each diagnostic group were not significantly different among Waves 1, 2, and 3. Conclusion The relatively low initial doses of aripiprazole documented in our study may reflect a strategy by clinicians to minimize the side effects associated with aripiprazole use, such as akathisia.

Collaboration


Dive into the Seunghee Won's collaboration.

Top Co-Authors

Avatar

Young Sup Woo

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Bo-Hyun Yoon

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Sung Man Chang

Kyungpook National University

View shared research outputs
Top Co-Authors

Avatar

Won-Myong Bahk

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Maeng Je Cho

Seoul National University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun-Young Lee

Seoul National University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge